Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +227.10%. A quarter ago, it was expected that this company would post earnings of $0.09 per share when it actually produced earnings of $0.06, delivering a surprise of -33.33%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Hims & Hers Health, which belongs to the Zacks Medical Info Systems industry, posted revenues of $617.82 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.22%. This compares to year-ago revenues of $481.14 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Hims & Hers Health shares have lost about 51.9% since the beginning of the year versus the S&P 500's gain of 0.9%.
What's Next for Hims & Hers Health?
While Hims & Hers Health has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Hims & Hers Health was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.13 on $645.27 million in revenues for the coming quarter and $0.55 on $2.73 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Info Systems is currently in the bottom 45% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
CareCloud, Inc. (CCLD), another stock in the same industry, has yet to report results for the quarter ended December 2025. The results are expected to be released on March 12.
This company is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of -52.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
CareCloud, Inc.'s revenues are expected to be $32.69 million, up 15.8% from the year-ago quarter.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
September New Jobs Expected to Drop to 90,000: Tonight’s Real “Bombshell” in Nonfarm Payrolls May Be Whether August Data Is Significantly Revised Down
Wall Street generally expects that new jobs added in September will drop to 90,000 and the unemployment rate will remain at 4.1%. The strong data in August was mainly boosted by unusual seasonal factors; the extent of their revision will directly affect perceptions of the strength of the September figures. As recent statements by Federal Reserve officials have pushed the probability of a rate hike in October down to 25%, market attention has shifted to long-term rates. Currently, systematic funds hold about $390 billion in global bond short positions. If the employment data unexpectedly disappoints, it could trigger severe market turbulence.
Retail Investors Stage a "Big Shrinking Circle"! JPMorgan Fund Flows Reveal Nvidia and SanDisk Attracting Funds Against the Trend, US Treasury ETF Returns to Retail Investors' Radar
Retail investors are concentrating their stock selections on a few targets related to computing power, storage, and large technology companies. On the bond side, another clear trend has emerged: amid continued pressure on long-term U.S. Treasury prices and persistently high yields, long-term Treasury ETFs saw a net inflow of $260 million during the week.
Strive stock closes at $30.11, up 2.38% as RSI flashes overbought signal
Macron calls for G7 coordination to address rising diesel prices, oil prices plunge in response, European stocks collectively rise
On October 2 local time, French President Macron called on the G7 to take coordinated action to avoid implementing export restrictions and jointly curb the rise in fuel prices. During a conference call among EU member country governments on Friday, parties discussed a proposal put forward by France: European countries would release 50 million barrels of diesel, and at the same time, International Energy Agency members would release 50 million barrels of crude oil.
Crypto prices
More
